Skip to main content
. 2016 Aug 11;16:406. doi: 10.1186/s12879-016-1731-8

Table 1.

Serotype distribution, demography and comorbidities of DENV infected patients

Characteristics N (%)
DENV serotypes
Mono-infection 222 (84.7)
 DENV-1 170 (76.6)
 DENV-2 44 (19.8)
 DENV-3 7 (3.2)
 DENV-4 1 (0.5)
Co-infection 40 (15.3)
 DENV-1/DENV-2 34 (85)
 DENV-1/DENV-3 5 (12.5)
 DENV-2/DENV-3 1 (2.5)
Race
 Malay 157 (59.9)
 Chinese 34 (13)
 Indian 29 (11.1)
 Foreign workers 37 (14.1)
 Others 5 (1.9)
 Male 146 (55.7)
Age groups
 <18 38 (14.5)
 18-29 104 (39.7)
 30-39 64 (24.4)
 40-49 27 (10.3)
 50-59 17 (6.5)
 >60 12 (4.6)
 Pregnancy 14 (5.3)
Comorbiditiesa 52 (19.8)
 Diabetes mellitus 21 (8)
 Hypertension 15 (5.7)
 Asthma 14 (5.3)
 Cardiovascular disease 6 (2.3)
 Blood disorderb 4 (1.5)
 Malignancyc 4 (1.5)
 Psychiatric disorders 4 (1.5)
 Othersd 5 (1.9)

aA patient may have more than one comorbidities

bIncludes G6PD deficiency (n = 2), beta-thalassaemia (n = 1), von Willebrand disease (n = 1)

cIncludes cancer of breast (n = 1), ear (n = 1), pancreas (n = 1), ovary (n = 1)

dOne patient each had- chronic obstructive airway disease, military tuberculosis, splenectomy, end stage renal failure, systemic lupus erythematosus